Conclusions: Our findings indicated that omega-3 fatty acid administration for 12 weeks among DN
patients had favorable effects on insulin levels, HOMA-B, QUICKI, serum triglycerides and VLDLcholesterol;
however, it did not influence biomarkers of inflammation and oxidative stress.